LYC Healthcare Berhad Income Statement

Financials in millions MYR. Fiscal year is April - March.

Millions MYR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	139.48	155.52	128.99	92.28	64.6	26.41
Revenue Growth (YoY)	-7.68%	20.57%	39.78%	42.86%	144.56%	112.43%
Cost of Revenue	79.69	86.55	60.72	50.7	32.41	14.79
Gross Profit	59.78	68.97	68.27	41.58	32.19	11.62
Selling, General & Admin	64.27	68.81	74.67	39.94	32.15	18.8
Other Operating Expenses	-4.49	-4.17	-6.01	-0.15	-7.63	-1.79
Operating Expenses	59.87	64.73	69.94	40.01	24.55	17.01
Operating Income	-0.09	4.24	-1.67	1.57	7.64	-5.39
Interest Expense	-11.3	-10.71	-9.47	-11.22	-8.76	-3.96
Interest & Investment Income	0.2	0.23	0.39	0.26	0.11	0.09
Earnings From Equity Investments	-0.03	-0.19	-1.4	-2.23	-0.51	-
Other Non Operating Income (Expenses)	-0.08	-0.08	-0.07	-0.05	-0.05	-0.03
EBT Excluding Unusual Items	-11.3	-6.5	-12.22	-11.67	-1.58	-9.29
Merger & Restructuring Charges	-	-	-0.07	-0.19	-0.29	-0.21
Asset Writedown	-1.59	-1.59	-0.55	-	-	-2.18
Other Unusual Items	-	-	-	-	0.64	0.5
Pretax Income	-12.89	-8.09	-12.84	-11.86	-1.22	-11.18
Income Tax Expense	3.93	4.13	3.68	2.93	3.03	0.28
Earnings From Continuing Operations	-16.82	-12.22	-16.52	-14.8	-4.25	-11.46
Net Income to Company	-16.82	-12.22	-16.52	-14.8	-4.25	-11.46
Minority Interest in Earnings	-2.75	-4.85	-4.26	-4.39	-4.97	-0.4
Net Income	-19.57	-17.07	-20.78	-19.19	-9.23	-11.87
Net Income to Common	-19.57	-17.07	-20.78	-19.19	-9.23	-11.87
Shares Outstanding (Basic)	738	715	715	550	436	362
Shares Outstanding (Diluted)	738	715	715	550	436	362
Shares Change (YoY)	2.54%	-	29.88%	26.33%	20.38%	9.20%
EPS (Basic)	-0.03	-0.02	-0.03	-0.03	-0.02	-0.03
EPS (Diluted)	-0.03	-0.02	-0.03	-0.03	-0.02	-0.03
Free Cash Flow	30.82	23.06	5.03	2.46	-2.54	-5.58
Free Cash Flow Per Share	0.04	0.03	0.01	0.00	-0.01	-0.01
Gross Margin	42.86%	44.35%	52.92%	45.06%	49.83%	44.00%
Operating Margin	-0.06%	2.73%	-1.29%	1.70%	11.83%	-20.39%
Profit Margin	-14.03%	-10.97%	-16.11%	-20.79%	-14.28%	-44.92%
Free Cash Flow Margin	22.10%	14.82%	3.90%	2.67%	-3.93%	-21.14%
EBITDA	7.96	12.37	5.92	4.84	10.4	-3.24
EBITDA Margin	5.71%	7.95%	4.59%	5.24%	16.10%	-12.28%
D&A For EBITDA	8.05	8.13	7.59	3.27	2.76	2.14
EBIT	-0.09	4.24	-1.67	1.57	7.64	-5.39
EBIT Margin	-0.06%	2.73%	-1.29%	1.70%	11.83%	-20.39%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.